When?
From: January 18, 2026 7:00 am
To: January 22, 2026 1:00 pm
Where?
Hyatt Regency Phoenix Hotel | Phoenix | Arizona
Neoplastic Hematopathology Tutorial 18 – 22 January 2026, Phoenix, Arizona
Continuing in the tradition of 40+ years of tutorials, the 2026 course is designed to update physicians on the latest advances in neoplastic hematopathology. It will be conducted under the direction of Dr. Daniel A. Arber at the Hyatt Regency Phoenix Hotel from January 18-22, 2026. The program will consist of lectures, case presentations, and discussions designed to provide pathologists, pathologists-in-training, and medical oncologists/ hematologists with an in-depth discussion of diagnostic problems that arise in neoplastic hematopathology.
Registration can be accessed via this link.
Further details and course agenda can be viewed here:
Read more
COURSE DIRECTORS
Get the most up-to-date information on the new lymphoma and leukemia classifications from the leaders in the field.
DANIEL A. ARBER, MD – Donald West and Mary Elizabeth King Professor and Chair, Department of Pathology, University of Chicago, Chicago, IL
ATTILIO ORAZI, MD – Professor and Chairman Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
-
Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;
-
State how to utilize recent advances in the classification of hematopoietic tumors;
-
Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;
-
Describe how to implement the most recent classification of hematologic neoplasms;
-
Recall new discoveries that might impact future classifications of hematologic neoplasms;
-
Understand the prognostic and therapeutic significance of new molecular genetic markers of these tumors.
ACCREDITATION AND CREDIT DESIGNATION
PHYSICIAN CREDIT
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMERICAN BOARD OF PATHOLOGY LIFELONG LEARNING (CME) CREDIT
This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 33.75 CME credits. Participants will earn credits equivalent to the amount of AMA PRA Category 1 Credits™ claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABPath Lifelong Learning (CME) credit.
OTHER HEALTH PROFESSIONAL CREDIT
Other Participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABPath. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.